Advertisement
Study highlights the utility of an easily calculated score, the MELD-XI, to predict post-transplant outcomes
Here’s what to look for in your patients
Data from Phase 2 study of ONC201 to be presented at ASCO
Findings suggest that a uniform dose can be an effective preventive strategy
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Cleveland Clinic experts discuss current guidelines and new research
How parents and families can make a big difference at home
Countermeasures reduce length of stay by more than 30%
Peanut-allergen powder approved by the FDA for the treatment of childhood peanut allergy
Testing a novel preventive strategy
Searching for new causes of familial cancer
Advertisement
Advertisement